Correlation of spectral domain optical coherence tomography characteristics with visual acuity in eyes with subfoveal scarring after treatment for wet age-related macular degeneration

Retina

Volumn 33, Issue 6, 2013, Pages 1249-1257

  El Emam, Sharif ^a   Chhablani, Jay ^a,b   Barteselli, Giulio ^a   Wang, Haiyan ^a   Lee, Su Na ^a   Kozak, Igor ^a   Cheng, Lingyun ^a   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b L V PRASAD EYE INSTITUTE   (India)

Author keywords

external limiting membrane; inner segment outer segment junction; spectral domain optic coherence tomography; subretinal scarring; visual acuity; wet age related macular degeneration

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL FEATURE; CORRELATION ANALYSIS; DEMOGRAPHY; DIODE LASER; EXUDATIVE MACULAR DEGENERATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE DAMAGE; PHOTODYNAMIC THERAPY; PREDICTOR VARIABLE; RETINA FOVEA; RETREATMENT; RETROSPECTIVE STUDY; SCAR FORMATION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CICATRIX; EPIRETINAL MEMBRANE; FEMALE; FOVEA CENTRALIS; HUMANS; MACULA LUTEA; MALE; MULTIVARIATE ANALYSIS; RETINAL PHOTORECEPTOR CELL INNER SEGMENT; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84878951798     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31827b6439     Document Type: Article

References (43)

1. Bressler NM, Bressler SB, Congdon NG, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 2003;121:1621-1624. (Pubitemid 37392370)
2. Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 2007;144:627-637.
3. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 1999; 117:1329-1345.
4. Slakter JS, Bochow TW, D'Amico DJ, et al. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology 2006;113:3-13. (Pubitemid 43021721)
5. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431. (Pubitemid 44511557)
6. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-372.e5.
7. Shin HJ, Chung H, Kim HC. Association between foveal microstructure and visual outcome in age-related macular degeneration. Retina 2011;31:1627-1636.
8. Rosenfeld PJ, Shapiro H, Tuomi L, et al. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology 2011;118: 523-530.
9. Duke-Elder WS. Textbook of Ophthalmology. Vol 3. London, United Kingdom: Henry Kimpton; 1947:2116
10. Riusala AM, Immonen IJ. Predictors of structural findings in old disciform lesions. Am J Ophthalmol 2004;138:245-253. (Pubitemid 39037429)
11. Doris N, Hart PM, Chakravarthy U, et al. Relation between macular morphology and visual function in patients with choroidal neovascularisation of age related macular degeneration. Br J Ophthalmol 2001;85:184-188. (Pubitemid 32146758)
12. Hogg R, Curry E, Muldrew A, et al. Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol 2003;87:609-614. (Pubitemid 36535336)
13. Byun YJ, Lee SJ, Koh HJ. Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Jpn J Ophthalmol 2010;54:571-577.
14. Kaiser PK, Blodi BA, Shapiro H, Acharya NR; MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:1868-1875.
15. Joeres S, Kaplowitz K, Brubaker JW, et al. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. Ophthalmology 2008;115:347-354.e2.
16. Hangai M, Ojima Y, Yoshida A, et al. [Improved visualization of foveal pathologies using Fourier-domain optical coherence tomography]. Nippon Ganka Gakkai Zasshi 2007;111:509-517.
17. Hangai M, Ojima Y, Gotoh N, et al. Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 2007;114:763-773. (Pubitemid 46483687)
18. Ota M, Tsujikawa A, Murakami T, et al. Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion. Br J Ophthalmol 2007;91:1644-1649. (Pubitemid 350207392)
19. Piccolino FC, de la Longrais RR, Ravera G, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005;139:87-99. (Pubitemid 40094844)
20. Aizawa S, Mitamura Y, Baba T, et al. Correlation between visual function and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa. Eye (Lond) 2009;23:304-308.
21. Li D, Kishi S. Loss of photoreceptor outer segment in acute zonal occult outer retinopathy. Arch Ophthalmol 2007;125: 1194-1200. (Pubitemid 47403025)
22. Otani T, Yamaguchi Y, Kishi S. Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 2010;30:774-780.
23. Wakabayashi T, Oshima Y, Fujimoto H, et al. Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology 2009;116:519-528.
24. Baba T, Yamamoto S, Arai M, et al. Correlation of visual recovery and presence of photoreceptor inner/outer segment junction in optical coherence images after successful macular hole repair. Retina 2008;28:453-458. (Pubitemid 351354947)
25. Hayashi H, Yamashiro K, Tsujikawa A, et al. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 2009;148:83-89.e1.
26. Sayanagi K, Sharma S, Kaiser PK. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 2009;93: 622-626.
27. Iida T, Yannuzzi LA, Spaide RF, et al. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 2003;23:1-7; quiz 137-138. (Pubitemid 36348476)
28. Zweifel SA, Engelbert M, Laud K, et al. Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol 2009;127:1596-1602.
29. Maheshwary AS, Oster SF, Yuson RM, et al. The association between percent disruption of the photoreceptor inner segmentouter segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol 2010;150:63-67.
30. Oster SF, Mojana F, Brar M, et al. Disruption of the photoreceptor inner segment/outer segment layer on spectral domainoptical coherence tomography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina 2010;30: 713-718.
31. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg 1997;13:388-391. (Pubitemid 27369067)
32. Oishi A, Hata M, Shimozono M, et al. The significance of external limiting membrane status for visual acuity in agerelated macular degeneration. Am J Ophthalmol 2010;150: 27-32.e1.
33. Sandberg MA, Brockhurst RJ, Gaudio AR, Berson EL. The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci 2005;46: 3349-3354. (Pubitemid 44264325)
34. Parravano M, Oddone F, Tedeschi M, et al. Retinal functional changes measured by microperimetry in neovascular agerelated macular degeneration patients treated with ranibizumab. Retina 2009;29:329-334.
35. Maruko I, Iida T, Sekiryu T, Saito M. Morphologic changes in the outer layer of the detached retina in rhegmatogenous retinal detachment and central serous chorioretinopathy. Am J Ophthalmol 2009;147:489-494.e1.
36. Salinas-Alamán A, García-Layana A, Maldonado MJ, et al. Using optical coherence tomography to monitor photodynamic therapy in age-related macular degeneration. Am J Ophthalmol 2005;140:23-28.
37. Kashani AH, Keane PA, Dustin L, et al. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:3366-3373.
38. Riusala A, Sarna S, Immonen I. Visual acuity and structural findings in old age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2005;243:947-950. (Pubitemid 41386721)
39. Keane PA, Liakopoulos S, Chang KT, et al. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 2008;115:2206-2214.
40. Keane PA, Patel PJ, Ouyang Y, et al. Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2010;51:5431-5437.
41. Calvo-Gonzalez C, Reche-Frutos J, Donate J, et al. Intravitreal ranibizumab for myopic choroidal neovascularization: factors predictive of visual outcome and need for retreatment. Am J Ophthalmol 2011;151:529-534.
42. Kuo JZ, Ong FS, Yeung L, et al. Predictive factors for visual outcome to intravitreal bevacizumab in young Chinese patients with myopic choroidal neovascularization. Retina 2011;31: 1835-1840.
43. Jonas JB, Tao Y, Rensch F. Bilateral intravitreal bevacizumab injection for exudative age-related macular degeneration: effect of baseline visual acuity. J Ocul Pharmacol Ther 2011;27: 401-405.